Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00738387

Public ClinicalTrials.gov record NCT00738387. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 29, 2026, 6:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-blind, Placebo-controlled Multi-center Study of ASA404 in Combination With Docetaxel in Second-line Treatment of Patients With Locally Advanced or Metastatic (Stage IIIb/IV) Non-small Cell Lung Cancer (NSCLC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if adding ASA404 to docetaxel chemotherapy makes the cancer treatment more effective in patients with locally advanced or metastatic non-small cell lung cancer

Study identification

NCT ID
NCT00738387
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
900 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2008
Primary completion
Nov 30, 2010
Completion
Not listed
Last update posted
Dec 23, 2020

Started 2008

United States locations

U.S. sites
88
U.S. states
26
U.S. cities
79
Facility City State ZIP Site status
Oncology Specialist, P.c. Huntsville Alabama 35805 —
Arizona Oncology Tucson Arizona 85704 —
Highlands Oncology Group Bentonville Arkansas 72712 —
Central Hematology Oncology Medical Group Alhambra California 91801 —
Comprehensive Blood and Cancer Center Bakersfield California 93309 —
Compassionate Cancer Care Medical Group Corona California 92879 —
Compassionate Cancer Care Medical Group Fountain Valley California 92708 —
St. Jude Heritage Healthcare Fullerton California 92835 —
Beaver Medical Group, L.P. Highland California 92346 —
Scripps Clinic La Jolla California 92037 —
University of Southern Californa Los Angeles California 90033-0800 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
UCLA Los Angeles California 90095 —
North Valley Hematology/Oncology Medical Group Northridge California 91325 —
University of California Irvine Medical Center Orange California 92868 —
Ventura County Hematology/Oncology Specialists Oxnard California 93030 —
Palo Alto Medical Foundation - Camino Div. Palo Alto California 94301 —
Bay Area Cancer Research Group Pleasant Hill California 94523 —
Loma Linda Oncology Medical Group, Inc. Redlands California 92374 —
Compassionate Cancer Care Medical Group Riverside California 92501 —
California Pacific Medical Research Institute San Francisco California 94115 —
University of California - SF San Francisco California 94115 —
Stanford Cancer Center Stanford California 94305 —
Rocky Mountain Cancer Center Denver Colorado 80218 —
Georgetown University Hospital Washington D.C. District of Columbia 21113 —
Advanced Medical Specialties Miami Florida 33176 —
Florida Cancer Institute New Port Richey Florida 34655 —
Ocala Oncology Center Ocala Florida 34474 —
Florida Hospital Cancer Institute Orlando Florida 32804 —
Cancer Centers of Florida, PA Orlando Florida 32806 —
Hematology/Oncology Associates of Treasure Coast Port Saint Lucie Florida 34952 —
Suburban Hematology-Oncology Lawrenceville Georgia 30045 —
Cancer Care Specialists of Central Illinois Decatur Illinois 62526 —
Comprehensive Cancer Program Harvey Illinois 60426 —
Cancer Care & Hematology Specialists of Chicagoland Niles Illinois 60714 —
OSF Center for Cancer Care Rockford Illinois 61108-2472 —
Loyola Cancer Care and Research Center Winfield Illinois 60190 —
Central Indiana Cancer Centers Indianapolis Indiana 46219 —
Horizon Oncology Center Lafayette Indiana 47905 —
Providence Medical Group Terre Haute Indiana 47802 —
Siouxland Hematology-Oncology Associates Sioux City Iowa 51101 —
Kansas City Cancer care, Southwest Overland Park Kansas 66210 —
University of Kansas Medical Center Westwood Kansas 66205 —
Cancer Center of Texas Wichita Kansas 67214 —
James Graham Brown Cancer Center Louisville Kentucky 40202 —
Western Kentucky Hematology & Oncology Paducah Kentucky 42003 —
Harry & Jeannette Weinberg Cancer Institute Baltimore Maryland 21237 —
Missouri Cancer Associates Columbia Missouri 65201 —
St. John's Mercy Medical Center St Louis Missouri 63141 —
Comprehensive Cancer Centers of Nevada Henderson Nevada 89074 —
Nevada Cancer Institute Las Vegas Nevada 89135 —
New Mexico Cancer Center Albuquerque New Mexico 87109 —
Advanced Oncology Associates Armonk New York 10504 —
Arena Oncology Associates, P.C. Lake Success New York 11042 —
NY Oncology/Hematology - Latham Latham New York 12110 —
Winthrop Hematology/Oncology Mineola New York 11501 —
SUNY Upstate Medical University Syracuse New York 13210 —
Duke University Medical Center Durham North Carolina 27710 —
Cancer Center of North Carolina Raleigh North Carolina 27606 —
MetroHealth Medical Center Cleveland Ohio 44109 —
Hematology Oncology Consultants, Inc. Columbus Ohio 43235 —
Signal Point Hematology/Oncology, Inc. Middletown Ohio 45042 —
Kaiser Permanante, Northwest Region Portland Oregon 97227 —
St. Luke's Hospital & Healtth Network Bethlehem Pennsylvania 18015 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
Hollings Cancer Center Charleston South Carolina 29425 —
Sarah Cannon Research Institute Nashville Tennessee 37203 —
Texas Cancer center - Abilene Abilene Texas 79606 —
Texas Oncology - Arlington South Arlington Texas 76014-2084 —
Mamie McFadden Ward Cancer Ctr, Texas Oncology Beaumont Texas 77702-1449 —
Texas Cancer Center at Medical City Dallas Texas 75230 —
Texas Oncology at Presbyterian Hospital Dallas Texas 75231 —
Methodist Charlton Cancer Center Dallas Texas 75237 —
UT Southwester Med Ctr at Dallas Dallas Texas 75390 —
Texas Cancer Center - Denton Denton Texas 76210 —
Longview Cancer Center Longview Texas 75601 —
Texas Oncology - Allison Cancer Center Midland Texas 79701 —
Paris Regional Cancer Center Paris Texas 75460 —
Texas Cancer Center - Sherman Sherman Texas 75090 —
Tyler Cancer Center Tyler Texas 75702 —
Blood and Cancer Center of East Texas Tyler Texas 75791 —
Texas Oncology Cancer Care Center & Research Center Waco Texas 76712 —
Puget Sound Cancer Centers Edmonds Washington 98026 —
Fred Hutchinson Cancer Reseach Center Seattle Washington 98109 —
Puget Sound Cancer Center Seattle Washington 98133 —
Evergreen Hematology and Oncology Spokane Washington 99218 —
MultiCare Health System Tacoma Washington 98405 —
Northwest Cancer Specialists Vancouver Washington 98684 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00738387, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 23, 2020 · Synced Sep 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00738387 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →